By combining ICD-mediated chemotherapy, TLR4-STING co-activation, and PD-1/PD-L1 blockade, this system not only enhanced immediate tumor cytotoxicity but also established a long-lasting anti-tumor immune memory. This evidence concerns the gene TLR4 and neoplasm.